New Technologies In the $21 Billion Worldwide Diagnostic Industry are Transforming the Practice of Medicine
Research and Markets (researchandmarkets. com/reports/c8891) has announced the addition of Point of Care Diagnostic Testing - World Markets to their offering.
(PRWEB) November 10, 2004
This report examines of the worldwide Point of Care Diagnostic testing sector in a quantitative, business and market oriented treatment. Focusing on new technologies, new markets for near patient diagnostic products and new attitudes of patients and healthcare providers, this report is a sourcebook of data and analysis about the fastest growing sector of the $21 billion worldwide diagnostic industry whose products are transforming the practice of medicine.
The Point of Care Diagnostic Testing World Markets report describes products segments that are poised for a major new phase of growth fueled by the availability of new technology platforms an the demand for more efficient medical service.
Near patient tests, including those for blood glucose, pregnancy, ovulation, coagulation, cholesterol, drugs, infectious disease and various urine components, are in high demand as physicians and patients realize their potential for promoting improved health care.
The POC market for diagnostic tests in the United States increased at a phenomenal compounded annual growth rate, and many parts of the world market grew at comparable rates, with Germany as the leader in Europe and high rates of growth in rest of the world including Asia and Japan. This report examines market sizes and growth rates for important country markets in Europe and Asia, including China.
This report examines the three basic factors have driven the market for Point of Care diagnostic testing products, and looks at the POC marketÂ’s two general segments: the hospital market and the physicianÂ’s office. The POC market encompasses a large variety of IVD products ranging from moderate sized instrumented diagnostic systems serving larger institutional uses to single-use, disposable tests for individual home use.
This report discusses Point of Care Diagnostic product industry trends that are believed to influence POC testing, including demographic changes, reimbursement policies, regulations, and the availability of clinically valuable tests that will increase growth in this diagnostic category. Detailed discussions of regulatory requirements for point of care diagnostic products for the U. S., Japan, and the EU are presented.
The report also includes discussions of Competitive Outlook, and Market Strategies. It also covers specific at point of care testing areas such as Glucose Monitoring, Pregnancy Testing, Hepatitis Testing, Drugs of Abuse Screening Testing, Infectious Disease Testing, HIV, Coagulation Testing and Fertility Testing.
There is also an important discussion of the emerging technologies for point of care diagnostics and the implications of molecular biology and genomics for new rapid diagnostic tests. Exiting new technology areas such as Protein Sequencing, DNA Sequencing and The Human Genome Project are placed into the context of their impact on rapid diagnosis.
Market Trends and Forecasts in point of care diagnostics such as the move to electro-detection for rapid glucose analyzers, Mergers and Acquisitions of Diagnostic Companies, emerging rapid tests for infectious disease, Rt-pcr, new cardiac monitors and more are reported in detail, and the strategies of the key industry players is discussed.
Finally, this report summarizes the business developments of over 100 companies from all parts of the world that market and manufacture point of care diagnostic products. Key merger and acquisition data are included.
The Point of Care Diagnostic Testing World Markets report is constantly updated, so that all important developments throughout the current year are included in the report.
This report provides not only the factual details of the rapid diagnostic testing segment, but answers, “why it is significant” and “what does it mean for your company”. A leading expert in diagnostic testing and marketing wrote the report.
For more information visit http://www. researchandmarkets. com/reports/c8891 (http://www. researchandmarkets. com/reports/c8891)
Laura Wood
Senior Manager
Research and Markets
Press@researchandmarkets. com
Fax: +353 1 4100 980
###
